Benzinga · Sep 2, 2026
Jefferies Initiates Coverage On IperionX with Buy Rating, Announces Price Target of $26
Jefferies analyst Laurence Alexander initiates coverage on IperionX (NASDAQ:IPX) with a Buy rating and announces Price Target of $26.
NASDAQ · IPX
Basic Materials · Industrial Materials
$18.67
Down-$0.75 (-3.86%)
Updated Sep 13, 2026, 11:17 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
IPX closed at $18.67 after 19 trading sessions, down 23.95% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $19.44 | $19.49 | $18.61 | $18.67 | 238.31K |
| Sep 10, 2026 | $20.35 | $20.68 | $19.26 | $19.42 | 304.73K |
| Sep 9, 2026 | $22.49 | $23.08 | $21.24 | $21.29 | 218.17K |
| Sep 8, 2026 | $21.90 | $23.07 | $21.90 | $22.37 | 181.47K |
| Sep 4, 2026 | $21.50 | $22.03 | $21.2705 | $21.75 | 130.68K |
| Sep 3, 2026 | $21.66 | $22.48 | $21.50 | $21.72 | 143.35K |
| Sep 2, 2026 | $20.88 | $21.44 | $20.61 | $21.33 | 259.13K |
| Sep 1, 2026 | $20.99 | $21.69 | $20.67 | $20.73 | 289.93K |
| Aug 31, 2026 | $21.20 | $22.085 | $21.15 | $21.87 | 214.69K |
| Aug 28, 2026 | $22.57 | $22.805 | $20.8501 | $21.01 | 461.83K |
| Aug 27, 2026 | $21.22 | $22.9399 | $21.13 | $22.44 | 518.65K |
| Aug 26, 2026 | $22.06 | $22.48 | $20.97 | $21.03 | 234.52K |
| Aug 25, 2026 | $21.71 | $22.63 | $21.71 | $22.50 | 174.24K |
| Aug 24, 2026 | $22.56 | $22.98 | $21.22 | $21.71 | 248.73K |
| Aug 21, 2026 | $21.06 | $22.615 | $21.06 | $22.50 | 279.35K |
| Aug 20, 2026 | $20.88 | $20.88 | $20.05 | $20.635 | 366.37K |
| Aug 19, 2026 | $22.09 | $22.09 | $20.89 | $21.58 | 297.92K |
| Aug 18, 2026 | $23.30 | $23.93 | $22.24 | $22.25 | 203.71K |
| Aug 17, 2026 | $24.31 | $24.87 | $23.95 | $24.55 | 162.19K |
The latest Smart Investors Daily articles mentioning IPX.
IPX research
Company profile and research snapshot.
IperionX Ltd produces titanium critical minerals, titanium powders, and titanium end products for various industries. The company's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, recyclable, and have low carbon intensity. IperionX is producing titanium metal powders from titanium scrap at its operational pilot facility in Utah, It also owns a titan critical minerals project, the Titan Project, covering over 11,000 acres of critical minerals that include titanium, rare earth elements, silica sand, and zircon in Tennessee, United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 24, 2026 | CANACCORD GENUITY | Buy | — |
| Jun 3, 2026 | BELL POTTER SECURITIES | Buy | — |
| Nov 9, 2025 | BELL POTTER SECURITIES | Buy | — |
| Nov 8, 2025 | BELL POTTER SECURITIES | Buy | — |
| Sep 3, 2025 | CANACCORD GENUITY | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 2, 2026
Jefferies analyst Laurence Alexander initiates coverage on IperionX (NASDAQ:IPX) with a Buy rating and announces Price Target of $26.
Yahoo · Aug 31, 2026
SOUTH BOSTON, Va., Aug. 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) IperionX Limited announces that the U.S. Army has awarded Task Order 2 under the Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Low-Cost, Domestic Titanium for Defense Applications. IperionX’s SBIR Phase III IDIQ contract enables qualifying U.S. Government agencies to place project-specific orders collectively capped at US$99 m
Benzinga · Aug 21, 2026
SeekingAlpha · Aug 14, 2026
IperionX is compelling due to domestic titanium scarcity, strategic government support, and the Titan Critical Minerals Project's robust economics. See why IPX stock is a Buy.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IPX.
No results
No recent SID articles mention IPX.